Abenex acquires Cisbio Bioassays

Cisbio

Life Sciences solutions for pharmaceutical and biological research

Cisbio operates mostly in Life Sciences Drug Discovery. It also has a small In-Vitro Diagnostics business unit. It serves clients through both a direct sales organization and distributors. It has 3 overseas subsidiaries (USA, China, Japan). Life Sciences activities serve big pharmas as well as biotechs and university research institutes. They focus on developing reagents at early phases of the biopharma R&D value chain, when biotechs/pharmas perform series of key tests to bring therapeutic candidates to clinical trials. The group IVD activities manufacture reagents to perform tests on biological samples (e.g.: blood, urine, tissues) to diagnose diseases in medical laboratories.

Date of capital investment

June 2016

Type of deal

LMBO

Turnover

45m€

Number of employees

210

Date of transfer

October 2020

Type of transfer

Industrial sale to PerkinElmer